OOIR: Observatory of International Research

Papers

(The H4-Index of Gut Microbes is 60. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2021-08-01 to 2025-08-01.)

Article	Citations
Gut microbiota and tuberculosis infection: interaction and therapeutic potential	269
Late-onset sepsis treatment in very preterm infants alters longitudinal microbiome trajectory with lower abundance of Bifidobacterium despite probiotic supplementation	237
The ladder of regulatory stringency and balance: an application to the US FDA’s regulation of bacterial live therapeutics	228
Intestinal bacteria and colorectal cancer: etiology and treatment	206
Prolonged oral antimicrobial administration prevents doxorubicin-induced loss of active intestinal stem cells	193
Interactions and substrate selectivity within the SctRST complex of the type III secretion system of enteropathogenic Escherichia coli	158
Akkermansia muciniphila reduces susceptibility to Listeria monocytogenes infection in mice fed a high-fat diet	150
L. rhamnosus CNCM I-3690 survival, adaptation, and small bowel microbiome impact in human	131
Pasteurized Akkermansia muciniphila improves irritable bowel syndrome-like symptoms and related behavioral disorders in mice	125
Dietary fiber-based regulation of bile salt hydrolase activity in the gut microbiota and its relevance to human disease	120
The gut-joint axis mediates the TNF-induced RA process and PBMT therapeutic effects through the metabolites of gut microbiota	114
3'-Sialyllactose and B. infantis synergistically alleviate gut inflammation and barrier dysfunction by enriching cross-feeding bacteria for short-chain fatty acid biosyn	113
Opioid-induced dysbiosis of maternal gut microbiota during gestation alters offspring gut microbiota and pain sensitivity	109
Human milk oligosaccharide metabolism and antibiotic resistance in early gut colonizers: insights from bifidobacteria and lactobacilli in the maternal-infant microbiome	106
Faecal (or intestinal) microbiota transplant: a tool for repairing the gut microbiome	102
Recipient microbiome-related features predicting metabolic improvement following fecal microbiota transplantation in adults with severe obesity and metabolic syndrome: a secondary analysis of a phase	101
Modeling spatial interaction networks of the gut microbiota	97
Depletion of butyrate-producing microbes of the Firmicutes predicts nonresponse to FMT therapy in patients with recurrent Clostridium difficile infection	94
Escherichia coli triggers α-synuclein pathology in the LRRK2 transgenic mouse model of PD	92
Gut microbial features and dietary fiber intake predict gut microbiota response to resistant starch supplementation	88
Progress of linking gut microbiota and musculoskeletal health: casualty, mechanisms, and translational values	87
Limosilactobacillus reuteri DS0384 promotes intestinal epithelial maturation via the postbiotic effect in human intestinal organoids and infant mice	86
Antigenic operon fragmentation and diversification mechanism in Bacteroidota impacts gut metagenomics and pathobionts in Crohn's disease microlesions	84
Gut microbiota metabolite indole-3-acetic acid maintains intestinal epithelial homeostasis through mucin sulfation	83
Effect of diet on the evolution of gut commensal bacteria	81

Linking serum vitamin D levels with gut microbiota after 1-year lifestyle intervention with Mediterranean diet in patients with obesity and metabolic syndrome: a nested cross-sectional and prospective	81
Lactobacillus acidophilus ameliorates cholestatic liver injury through inhibiting bile acid synthesis and promoting bile acid excretion	81
Gut microbiota in nonalcoholic fatty liver disease: a PREDIMED-Plus trial sub analysis	80
Microbial succinate promotes the response to metformin by upregulating secretory immunoglobulin a in intestinal immunity	78
Microbiota during pregnancy and early life: role in maternal−neonatal outcomes based on human evidence	78
A high fiber diet or supplementation with Lactococcus lactis subspecies cremoris to pregnant mice confers protection against intestinal injury in adult offspring	78
Meta-analysis reveals Helicobacter pylori mutual exclusivity and reproducible gastric microbiome alterations during gastric carcinoma progression	77
Intestinal TLR4 deletion exacerbates acute pancreatitis through gut microbiota dysbiosis and Paneth cells deficiency	76
Clostridioides difficile aggravates dextran sulfate solution (DSS)-induced colitis by shaping the gut microbiota and promoting neutrophil recruitment	76
Communication between the gut microbiota and peripheral nervous system in health and chronic disease	75
Next-generation probiotics – do they open new therapeutic strategies for cancer patients?	75
Gut microbiota and radiation-induced injury: mechanistic insights and microbial therapies	75
The gut-skin axis: a bi-directional, microbiota-driven relationship with therapeutic potential	74
Washed microbiota transplantation promotes homing of group 3 innate lymphoid cells to the liver via the CXCL16/CXCR6 axis: a potential treatment for metabolic-associated fatty liver disease	73
Gut virome profiling identifies an association between temperate phages and colorectal cancer promoted by Helicobacter pylori infection	72
Ethanol-induced changes to the gut microbiome compromise the intestinal homeostasis: a review	72
High throughput genome scale modeling predicts microbial vitamin requirements contribute to gut microbiome community structure	71
Citrobacter rodentium possesses a functional type II secretion system necessary for successful host infection	70
Antidepressant drugs promote the spread of broad-host-range plasmid in mouse and human gut microbiota	70
The intestinal microbiome of inflammatory bowel disease across the pediatric age range	68
The microbiota and the host organism switch between cooperation and competition based on dietary iron levels	67
Dysbiotic but nonpathogenic shift in the fecal mycobiota of patients with rheumatoid arthritis	67
The regulatory effect of chitooligosaccharides on islet inflammation in T2D individuals after islet cell transplantation: the mechanism behind Candida albicans abundance	67
Long COVID and gut microbiome: insights into pathogenesis and therapeutics	66
Maternal milk fat globule membrane enriched gut L. murinus and circulating SCFAs to improve placental efficiency and fetal development in intrauterine growth restricted	65
The crystal structure of the toxin EspC from enteropathogenic Escherichia coli reveals the mechanism that governs host cell entry and cytotoxicity	65
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease	65
Engineered bacteria as an orally administered anti-viral treatment and immunization system	64
Gut microbiome diversity, variability, and latent community types compared with shifts in body weight during the freshman year of college in dormitory-housed adolescents	62
Gut microbiota drives structural variation of exogenous probiotics to enhance colonization	61
Candida albicans can foster gut dysbiosis and systemic inflammation during HIV infection	60
Acids produced by lactobacilli inhibit the growth of commensal Lachnospiraceae and S24-7 bacteria	60
Regulation of flagellar motility and biosynthesis in enterohemorrhagic Escherichia coli O157:H7	60
Mucus-penetrating microbiota drive chronic low-grade intestinal inflammation and metabolic dysregulation	60
Multi-strain probiotics during pregnancy in women with obesity influence infant gut microbiome development: results from a randomized, double-blind placebo-controlled study	60